Health
Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers – News-Medical.Net
It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced “highly…
It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced “highly significant” news about a drug called remdesivir.
That was surprising because the antiviral drug, owned by Gilead Sciences and developed with investment from the federal government, had languished for years with no apparent commercial use. It had struck out as a treatment for hepatitis C and Ebola.
But early in 2020, when the first global…
-
Noosa News15 hours agoBrisbane State High School apologises after teaching wrong topic for Year 12 exam
-
Noosa News21 hours agoBands rock for Uriah | Noosa Today
-
General13 hours agoWoman in custody for allegedly cutting gas services at Sutherland hospitals in Sydney
-
Noosa News11 hours agoFarm owner cleared of all charges over worker’s electrocution